Bacillus cereus: Difference between revisions
From IDWiki
Bacillus cereus
(Created page with "{{DISPLAYTITLE:''Bacillus cereus''}} == Background == * Stain::Gram-positive Shape::bacillus within the genus Genus::Bacillus == Management == * Almost universally resistant to penicillins and co-trimoxazole * Usually susceptible to vancomycin, linezolid, ciprofloxacin (more than levofloxacin), and tetracycline<ref>Mills E, Sullivan E, Kovac J. Comparative Analysis of Bacillus cereus Group Isolates' Resistance Using Disk Diffus...") |
mNo edit summary |
||
| Line 8: | Line 8: | ||
* Almost universally resistant to [[penicillins]] and [[co-trimoxazole]] |
* Almost universally resistant to [[penicillins]] and [[co-trimoxazole]] |
||
* Usually susceptible to [[vancomycin]], [[linezolid]], [[ciprofloxacin]] (more than [[levofloxacin]]), and [[tetracycline]] |
* Usually susceptible to [[vancomycin]], [[linezolid]], [[ciprofloxacin]] (more than [[levofloxacin]]), and [[tetracycline]][[CiteRef::elkins2022co]] |
||
[[Category:Gram-positive bacilli]] |
[[Category:Gram-positive bacilli]] |
||
Latest revision as of 17:18, 19 September 2024
Background
- Gram-positive bacillus within the genus Bacillus
Management
- Almost universally resistant to penicillins and co-trimoxazole
- Usually susceptible to vancomycin, linezolid, ciprofloxacin (more than levofloxacin), and tetracycline1
References
- ^ Emma Mills, Erin Sullivan, Jasna Kovac. Christopher A. Elkins. Comparative Analysis of Bacillus cereus Group Isolates' Resistance Using Disk Diffusion and Broth Microdilution and the Correlation between Antimicrobial Resistance Phenotypes and Genotypes. Applied and Environmental Microbiology. 2022;88(6). doi:10.1128/aem.02302-21.
